Polaris AI Pharma
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Polaris AI Pharma is a pharmaceutical company listed on KOSDAQ, South Korea's tech and small-cap stock exchange.
The filing's business description is largely a table of contents without substantive product or operational detail, so the specific medicines or health-care products it supplies, and the customers it serves, cannot be confirmed from the available text.
Summary is AI-generated and may contain errors · figures from DART filings
Polaris AI Pharma in five facts
What does Polaris AI Pharma do?
Polaris AI Pharma is a pharmaceutical company listed on KOSDAQ, South Korea's tech and small-cap stock exchange.
Where is Polaris AI Pharma listed and in which sector?
Polaris AI Pharma (Korean name: 폴라리스AI파마) trades under KRX code 041910 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Polaris AI Pharma?
Its market capitalisation was US$57.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Polaris AI Pharma's latest annual revenue and operating profit?
For fiscal year 2025, Polaris AI Pharma reported revenue of US$41.9M, operating profit of US$2.4M and net income of US$4.7M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was down 6.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Material event report (convertible bonds)
Polaris AI Pharma updated the terms of convertible bonds to raise US$6.66M, about 13.6% of its market value.
Capital raise · Mar 26 · 2 versions - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Polaris AI Pharma reported separate results for FY2025: revenue of US$37.5M (−6.8% year on year), operating profit of US$2.16M (+1712.2% year on year) and net income of US$4.16M (+56.1% year on year).
Earnings · Mar 6